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The 2013–2016 Ebola outbreak inWestAfrica is the largest on recordwith 28 616
confirmed, probable and suspected cases and 11 310 deaths officially recorded
by 10 June 2016, the true burden probably considerably higher. The case fatality
ratio (CFR: proportion of cases that are fatal) is a key indicator of disease severity
useful for gauging the appropriate public health response and for evaluating
treatment benefits, if estimated accurately. We analysed individual-level clinical
outcome data from Guinea, Liberia and Sierra Leone officially reported to the
World Health Organization. The overall mean CFR was 62.9% (95% CI: 61.9%
to 64.0%) among confirmed cases with recorded clinical outcomes. Age was
the most important modifier of survival probabilities, but country, stage of the
epidemic and whether patients were hospitalized also played roles. We devel-
oped a statistical analysis to detect outliers in CFR between districts of
residence and treatment centres (TCs), adjusting for known factors influencing
survival and identified eight districts and three TCs with a CFR significantly
different from the average. From the current dataset, we cannot determine
whether the observed variation in CFR seen by district or treatment centre
reflects real differences in survival, related to the quality of care or other factors
or was caused by differences in reporting practices or case ascertainment.
This article is part of the themed issue ‘The 2013–2016 West African
Ebola epidemic: data, decision-making and disease control’.1. Introduction
Ebola virus disease (EVD) is a viral haemorrhagic fever (VHF) and one of the
most deadly human pathogens known, with reported case fatality ratios
(CFRs) from previous outbreaks typically in the range 70–90% for the most
severe Zaire strain that has caused the recent outbreak in West Africa [1],
although a CFR as low as 44% (95% CI 26–62%) has also been reported [2].
During the 2013–2016 outbreak, 28 616 confirmed, probable and suspected
cases and 11 310 deaths were officially reported to the World Health
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Guinea, Liberia and Sierra Leone by 10 June 2016 [3]. With
large-scale transmission interrupted in all three countries
the Public Health Emergency of International Concern was
lifted on 29 March 2016 [3] despite the fact that one might
expect further resurgences, for instance due to low-level
unobserved ongoing transmission or incomplete clearance
or reactivation of the virus in some survivors.
Throughout this outbreak estimates of the CFR have
varied widely, depending on the sub-population studied
and the methods employed [4–14]. Early estimates often
simply estimated CFR by using the number of deaths divided
by the number of cases reported to date [15,16]. These esti-
mates did not consider the fact that in a growing outbreak
a significant proportion of reported cases may yet die, or
the fact that the clinical outcome is only reported in a fraction
of cases, therefore under-estimating the true CFR [17,18].
While estimates of the CFR stemming from analysis of the
whole outbreak have been in line with those reported from
previous outbreaks, typically around 60–70% [11,12,19],
CFR estimates from smaller studies have been more variable
and often considerably lower [4–10,13], owing to the fact that
the study populations were not representative of the overall
characteristics of reported cases, for instance often focusing
on hospitalized cases only.
Understanding factors influencing mortality is important
to not only understand the severity of a pathogen and factors
associated with differences in mortality, but also to improve
patient care. For example, the evaluation of the efficacy
of treatment regimens or new drugs relies on accurate
baseline CFR estimates, and study design of randomized con-
trolled trials can be adapted to take into account important
determinants of patient outcomes [7]. A strength of small,
patient-based studies to investigate determinants of the CFR
are the often well-defined inclusion criteria and comparability
between different study arms or strata. This may allow for an
assessment if not adjustment of biases in CFR estimates result-
ing from the study design. However, the limited scope can
make it impossible to detect some of the factors influencing
mortality, and therefore a bird’s eye view of the situation is
crucial to fully capture the observed heterogeneities.
Here, we estimate the CFR of EVD in the West African
outbreak from a comprehensive individual-based dataset of
cases reported officially to the WHO and we investigate
factors modifying the CFR. We assess spatial heterogeneity
in mortality by stratifying CFR estimates by district and treat-
ment centre (TC) and identify outliers of significantly lower
or higher CFR than expected. This enhances the understand-
ing of drivers of mortality and highlights which districts or
TCs could be investigated further to understand the reasons
for the unusual outcome composition recorded there.2. Material and methods
(a) Dataset
We analysed the VHF database of cases reported officially to
the WHO during the 2013–2016 Ebola outbreak in Guinea,
Liberia and Sierra Leone as previously described [11], updated
on the 28 September 2015 including updates from Guinea on
27 September, from Liberia on 4 May and from Sierra Leone
on 28 September. This dataset included data on individual
cases using a ‘VHF case investigation form’ recording (amonga large number of other variables) clinical outcome, epidemiolo-
gical case classification, demographic information such as age
and gender, location of residence, hospitalization status
(i.e. whether cases were hospitalized), and TC as well as dates
of case report, symptom onset, hospitalization, death or recovery
and outcome report. We performed extensive data cleaning as
previously described [11,12]. Location of residence was geo-
coded to the second administrative level, termed prefecture in
Guinea, county in Liberia and district in Sierra Leone. For con-
ciseness, we refer to this as district for all countries throughout.
For cases with missing date of symptom onset, we inferred a
likely date based on other dates recorded, such as the dates of
report or hospitalization, and the median delay observed
between the events in question in the current dataset, following
methods developed earlier [11]. We publish the cleaned version
of this dataset as electronic supplementary materials 1 and 2,
including a subset of the recorded variables that are necessary
to perform the analyses presented here.
We estimated the CFR as the percentage of fatalities among
cases with reported definitive clinical outcome (dead/alive). As
in previous analyses of the CFR [11,12,20,21], we only considered
cases which were reported prior to their clinical outcome
being known, as cases reported retrospectively were heavily
biased towards fatal outcomes through case detection associated
with burial teams finding bodies. We therefore excluded any
cases for which the date of report was on or after the date of out-
come recording, if both dates were given. We refer to this as
‘retrospective reports’ throughout.
Individuals in the dataset were classified into five epidemiolo-
gical case classifications: confirmed, probable, suspected, not a
case, and excluded. Official case definitions were based on clinical
symptoms and testing [22], though interpretations probably dif-
fered between countries, with the most complete and consistent
recording among confirmed cases across the three countries.
While the overall extent of the epidemic is likely best described
using a fairly inclusive case definition with probable and perhaps
suspected cases included, here we focus exclusively on confirmed
cases to obtain less-biased estimates of the CFR by restricting to
the most reliably recorded subset of cases despite the resulting
smaller sample size. However, as a sensitivity analysis we also
present the main results having included both confirmed and
probable cases in electronic supplementary material 3.
We classified TCs broadly into five types: Ebola Treatment
Unit (ETU), Hospital, Holding Centre, Community Care Centre
(CCC), Health Centre, and added a category for those of
unknown type, and two further categories for patients never
hospitalized or of unknown hospitalization status (for further
details see the text box 1 and table S1 in electronic supplementary
material 3). We refer to those who were recorded in any of the
five TC types as ‘hospitalized cases’ throughout.(b) Analyses
(i) Identifying individual-level predictors of mortality
We investigated the extent to which variables could explain
clinical outcome by calculating stratified CFR estimates and
performing x2-tests, and using uni- and multivariable logistic
regression models.
We calculated the CFR stratified by TC type and country and
performed pairwise comparisons between strata (i.e. 21 compari-
sons), assessing significance using x2-tests and implementing a
Bonferroni correction [23] to adjust for multiple testing.
We investigated the effect of the delay from onset to hospital-
ization on clinical outcome by performing a x2-test between
patients hospitalized within 3 days of symptom onset to those
hospitalized later. We furthermore fitted a univariable logistic
regression model between clinical outcome and the delay from
onset to hospitalization.
Box 1. Treatment centre classification.
We classified treatment centres (TCs) broadly into five types:
1. Ebola Treatment Units (ETUs)—purpose-built or repurposed buildings designated for the care and management of Ebola
patients. These admitted patients with suspected EVD or with confirmed EVD referred from other healthcare units,
although the admission and referral procedures varied between facilities.
2.Hospitals—hospitalwards in existing hospitals. Somehospitals had isolation facilities for suspected or confirmedEVDpatients.
3. Holding Centres—basic facilities to isolate suspected EVD patients until laboratory confirmation, following which patients
should be transferred to an ETU if beds were available.
4. Community Care Centres (CCCs)—set up to alleviate pressure from ETUs by providing basic care and isolation to suspected
EVD patients. Staffing levels were lower than in ETUs, and sometimes relatives provided care within the CCC setting.
5. Health Centres—we classified a variety of healthcare facilities as Health Centres, including those described as Case Man-
agement Centre, Clinic, Health Centre, Health Post, Health Unit, Maternal and Child Health Post or Referral Centre.
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we fitted logistic regression models with age as a trend, separ-
ately for individuals under 15 years and individuals 15 years
and older (here referred to as children and adults, respectively)
to capture the observed age dependence, by defining child age
achild and adult age aadult as separate variables,
achild ¼ minða 15, 0Þ aadult ¼ maxða 15, 0Þ,
where a is the age in years, and including these in the regression.
Date of onset was aggregated into quarters and investigated
both as a linear trend and as a categorical variable, while we
investigated both hospitalization status (recorded as yes, no or
missing), and TC type as categorical variables using logistic
regression. For all categorical variables, we chose the largest
category as the reference.
We fitted multivariable logistic regression models using all
possible combinations of the covariates that were significantly
associated with clinical outcome in univariable regression. For
date of onset, we tested both inclusion as a trend or as a categori-
cal variable. We chose the model with minimal value of Akaike’s
Information Criterion (AIC) [24] as the most parsimonious multi-
variable regression model to avoid overfitting and to only
include variables that were independently associated with
the outcome.
(ii) Assessing heterogeneity in district- and treatment centre-
specific case fatality ratio
We assessed heterogeneities in CFR between districts and TCs
following methods used to identify outlier healthcare units
from routinely collected outcome data in the UK National
Health Service [25]. To evaluate whether variability in CFR esti-
mates was larger than would be expected by chance we plotted
district- and TC-specific estimates against their sample sizes in
funnel plots [26], highlighting the range of variation expected
under a binomial process with the same overall mean by also
plotting relevant quantiles of the binomial distribution with
this mean for each sample size.
The case mix, i.e. the composition of the cases in terms of the
covariates considered in these analyses, such as age and onset
date, differed between districts and between TCs. We adjusted
for case mix in individual districts or TCs based on the variables
identified in the best-fitting multivariable regression models
when fitted to the subset of cases for which the district of resi-
dence was recorded, or which were hospitalized with the TC
recorded, respectively. For this, we calculated model predictions
(i.e. the probability of death) for all cases based on their covari-
ates, and averaged over all cases within a district or TC to
obtain the expected CFR. Here, we excluded cases from districts
or TCs with less than 10 cases. To avoid undue influence ofpotential outliers on the results, we used a full cross-validation
approach by refitting the model omitting each district or TC in
turn and generated model predictions (i.e. the probability of
death) for the omitted TC. We then simulated outcomes for
these cases based on the model predictions, resampling each
district or TC nsim ¼ 250 000 times, and compared the observed
number of deaths with the distribution of simulated outcomes
to evaluate the probability of a result at least as extreme as the
observed number of deaths among cases, evaluating the pro-
portion p of these realizations that resulted in a CFR lower
than the observed. The raw p-value for a significantly lower
than expected CFR was evaluated as plow ¼ 2p/nsim, while
the raw p-value for a significantly higher than expected CFR
was phigh ¼ 2(1 2 p)/nsim. We adjusted these raw p-values for
multiple testing using a Bonferroni correction.3. Results
In contrast with the 28 616 cases quoted in WHO situation
reports, there were a total of 33 338 confirmed, probable and
suspected cases reported by 28 September 2015 recorded in
the VHF database analysed here (table 1; electronic sup-
plementary materials 1 and 2). For evaluating the CFR, we
only considered the 8413 confirmed cases with known clinical
outcome that were reported prospectively rather than retro-
spectively (tables S2 and S3 in electronic supplementary
material 3). As expected, cases reported retrospectively were
heavily biased towards corpses found post-mortem, and
indeed the CFR among these was much higher at 91.3%
(95% CI 89.5–92.9%) among confirmed cases from all three
countries together (figure S1 in electronic supplementary
material 3).
Completeness of reporting the clinical outcome was highly
variable between countries, epidemiological case definitions
and over time (figure 1, as well as figures S3 and S5 in elec-
tronic supplementary material 3), with outcomes more likely
reported in confirmed cases overall, while CFR estimates
were lower and more consistent between countries in
confirmed cases than in probable or suspected cases.
In Guinea, the outcome was reported in nearly all con-
firmed cases, while in Liberia and Sierra Leone reporting
rates of clinical outcome dropped drastically during the
peak of the epidemic (August–December 2014) when
healthcare systems were at their most overstretched.
Other variables investigated, including date of symptom
onset, age, district of residence, and, for hospitalized cases, TC
Table 1. Number of cases by country and epidemiological case deﬁnition, including retrospectively reported cases, and percentage of retrospectively reported
cases (which were excluded from further analysis), among conﬁrmed cases.
all countries Guinea Liberia Sierra Leone
conﬁrmed 16 444 3304 3743 9397
probable 3910 443 1600 1867
suspected 12 984 10 2787 10 187
total 33 338 3757 8130 21 451
% reported retrospectively 6.5 14.9 4.4 4.3
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Figure 1. (a) Percentage of confirmed cases with reported definitive clinical outcome. (b) Estimated CFR, both with 95% confidence interval (CI) by country
and month of onset (inferred). Only data for months with 10 or more confirmed cases (in the particular country) are shown.
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pletely (figure S2 in electronic supplementary material 3), with
around 20% of onset dates missing. For nearly all cases with
missing symptom onset date, we were able to infer the likely
onset date based on other recorded dates (such as the date of
case report). Age and district of residence were recorded in
around 95% of cases, while the hospitalization status was only
recorded for 75% of patients. Among those hospitalized, the
particular TC was missing in around 20% of patients and both
TC type and the onset to hospitalization delay were missing
for around a quarter of patients.
The overall CFR among the 8413 confirmed cases in the
three countries for which the clinical outcome was reported
was 62.9% (95% CI 61.9–64.0%). Several factors were associ-
ated with the observed CFR, including age, the epidemic
stage (defined by the quarter of the year) and hospitalization
status (figure 2; see also figure S7 in electronic supplementary
material 3 for absolute frequencies of the covariates con-
sidered). The reported delay from symptom onset to
hospitalization was not associated with the clinical outcome
( p ¼ 0.21 in a x2-test and p ¼ 0.68 when fitted as a trend in
a logistic regression model).
Age had a profound effect on survival. The CFR in chil-
dren was highest in children under the age of 5 at 75.6%
(95% CI 71.6–79.2%), decreased with age throughout adoles-
cence, until it reached a minimum at 47.9% (95% CI 45.0–
50.8%) in the teenage age groups from 10 to 19 years, and
then increased steadily with age with the highest rates at
83.9% (95% CI 77.0–89.0%) in the elderly over the age of 75in the three countries overall. This pattern was consistent
across all three countries. A logistic regression model treating
the effect of age as a trend separately in children and adults
captured the observed pattern very well ( p, 0.001; see
figure 2a; figure S6 in electronic supplementary material 3),
although there was substantial heterogeneity in the data
that was not explained by this simple model. Allowing
country-specific differences in the overall levels of CFR was
a significant model improvement ( p, 0.001), but the age
trends were not significantly different between countries
( p ¼ 0.11).
The estimated CFR varied throughout the epidemic, with
a decreasing trend overall, from 69.8% (95% CI 58.6–79.2%)
between January and March 2014 to 39.0% (95% CI 25.7–
54.3%) between July and September 2015 for all countries
combined (figure 2b). This was driven by the decreases in
Guinea and Liberia, while the high CFR during the peak
with lower values early and late in the epidemic in Sierra
Leone mirrored the pattern of clinical outcome reporting
and meant that fitting the quarter of onset as a categorical
variable improved model fit significantly, whether country
was included as additional factor or not (p, 0.001 without
and with country). Including country into the model was
also a significant improvement ( p, 0.001).
TCs of unknown type had a significantly lower CFR at
49.8% (95% CI 47.4–52.2%) than ETUs (54.5%, 95% CI
52.9–56.1%, p ¼ 0.033) and Health Centres (58.0%, 95% CI
54.0–62.0%, p ¼ 0.015). Those not hospitalized (CFR 90.6%,
95% CI 88.7–92.2%) or of unknown hospitalization status
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Figure 2. CFR by (a) age in 5-year age bands, (b) quarter, (c) Treatment Centre type, for all countries combined and by country for confirmed cases, with 95% CI.
Only strata with 10 or more confirmed cases are shown. Note that there were no Community Care Centres with 10 or more cases with reported clinical outcome. (a)
The solid black line shows the prediction from a logistic regression model with age fitted as a linear trend in children and adults separately with 95% CI (grey area),
shown for all countries combined to keep the figure simple. Country-specific fits are shown in figure S6 in electronic supplementary material 3.
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CFR than those hospitalized in any of the TC types (all p,
0.001; figure 2c).
The best-fitting multivariable regression model (selected
based on the minimal AIC value) included age, country,
inferred date of symptom onset (as a categorical variable
for district-based analysis and as a linear trend for TC-based
analysis) and TC type (for model parameters see tables S4
and S5 in electronic supplementary material 3). The district-
based analysis included 8034 confirmed cases for which the
district, the clinical outcome and the considered covariates
were recorded, while the TC-based analysis only included a
total of 4865 hospitalized cases with the required data
recorded. This smaller underlying dataset resulted in lower
statistical power, and therefore the AIC favoured a slightly
simpler model fitting the date of symptom onset as a
linear trend rather than as a categorical variable (as in the
district-based analysis).
Based on these models, we predicted the expected CFR
for each district or TC, respectively, and compared the predic-
tions with the observed CFR. Figure 3 shows the district- orTC-specific CFR estimates plotted against the number of
reported confirmed cases for each district or TC. In the
absence of any significant differences, we would expect
larger variation around the overall mean (63.4% (95% CI
62.3–64.4%) and 54.4% (95% CI 52.9–55.8%) for the district-
and TC-based analyses, respectively) for small than for large
sample sizes as indicated by the funnel. The saw-tooth
appearance of the funnel stems from the fact that sample
size is discrete, with the expected number of deaths increas-
ing at approximately every other step in sample size for a
grand mean CFR in the order of 50%, leading to small
fairly regular fluctuations in the plotted quantiles as a func-
tion of the sample size. There was considerable variation
beyond what would be expected by chance, both between
districts and between TCs, with 14 of 43 districts and 18
of 66 TCs falling outside the 95% funnel (see also figure S8
in electronic supplementary material 3).
We adjusted for case mix within each district or TC based
on the multivariable regression models to compare individ-
ual observed CFRs to what would be expected for the
particular district or TC, rather than the grand mean among
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Figure 3. Funnel plot of the CFR by (a) district of residence and (b) TC, for confirmed cases. Only districts and TCs with 10 or more confirmed cases are included.
Districts and TCs with significantly high or low CFR after adjusting for covariates are marked with diamonds and squares, respectively. Blue solid and dotted lines
show the 95% and 99% binomial confidence intervals, respectively, for each sample size assuming the mean CFR of the patients included in these analyses (dashed
blue line).
Table 2. Districts with signiﬁcantly lower or higher CFR among conﬁrmed cases than expected.
country district N observed CFR (95% CI) expected CFRa (95% CI) direction p-value
Guinea Conakry 462 39.6 (35.3–44.1) 54.6 (50.1–59.1) low ,0.001
Sierra Leone Moyamba 195 53.3 (46.3–60.2) 66.9 (60–73.1) low ,0.001
Sierra Leone Kambia 157 61.1 (53.3–68.4) 79.3 (72.3–84.9) low ,0.001
Guinea Gueckedou 236 72.9 (66.9–78.2) 56.2 (49.8–62.4) high ,0.001
Sierra Leone Western 733 84.3 (81.5–86.8) 74.2 (70.9–77.2) high ,0.001
Liberia Lofa 294 67.7 (62.1–72.8) 57.6 (51.9–63.1) high 0.0082
Sierra Leone Tonkolili 70 78.6 (67.6–86.6) 60.7 (49–71.3) high 0.011
Sierra Leone Kenema 431 67.1 (62.5–71.3) 61.2 (56.5–65.7) high 0.023
aExpected based on case mix adjusting for country, age, quarter of onset (ﬁtted as a categorical variable) and TC type.
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tricts of residence and three TCs with a CFR significantly
different from the expected (tables 2 and 3). Three districts
had significantly lower and five significantly higher CFR
than expected, and some but not all of these fell outside the
funnel that indicates the expected variation from the overall
CFR for any particular sample size, not accounting for case
mix. Case mix explained even more of the variability in
CFR between TCs, with only three TCs identified as outliers.
The two TC outliers in Guinea were in districts that were also
identified as outliers. This is not surprising as the majority of
cases from these districts were hospitalized in these local TCs,
although both TCs cared for substantial numbers of cases
from outside the district also.
4. Discussion
In this study, we evaluated the CFR in the 2013–2016 Ebola
outbreak in West Africa, using individual-level clinical out-
come data, which allowed us to investigate the effects of
several covariates on outcomes. As found in earlier analyses,CFR varied by age (with lowest CFRs found in teenagers, and
higher CFRs in young children as well as increasing with age
in adults), over time (with a decreasing trend in Guinea and
Liberia, but highest values during the peak around October
2014 in Sierra Leone) and by hospitalization status, i.e.
whether or not cases were hospitalized (with hospitalized
cases significantly less likely to die) [11,12,20,21,27]. We
found considerable spatial heterogeneities in CFR between
districts and TCs, some of which we explained with the avail-
able covariates, and identified outliers among districts and
TCs for which the observed CFR was significantly different
from what would be expected after adjusting for the case
mix based on the identified covariates.
Despite the very simple definition of the CFR and its
importance for public health planning, it is surprisingly diffi-
cult to estimate it accurately in outbreak situations as the data
are frequently collected under challenging circumstances and
not specifically gathered for this purpose, which can lead to
potentially substantial biases [18]. The main biases that
might affect the validity of the present study stem from
incomplete reporting at two levels.
Table 3. Treatment centres with signiﬁcantly lower or higher CFR among conﬁrmed cases than expected.
country treatment centrea N observed CFR (95% CI) expected CFRb (95% CI) direction p-value
Guinea Conakry 2 774 42 (38.6–45.5) 54.9 (51.4–58.4) low ,0.001
Guinea Gueckedou 1 982 59.2 (56.1–62.2) 46.7 (43.6–49.8) high ,0.001
Liberia Montserrado 65 36 86.1 (71.3–93.9) 59.5 (43.3–73.8) high 0.0023
aTreatment centre names were anonymized within district.
bExpected based on case mix adjusting for country, age, quarter of onset (ﬁtted as trend) and TC type.
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in estimates of the CFR if the reasons for cases being officially
reported are correlated with the outcome, for instance when
more severe cases are more likely to be reported. In the
2013–2016 Ebola outbreak substantial underreporting rates
were estimated [28,29]. There were several mechanisms for
cases to be entered into the database, including through noti-
fication via phone hotlines, at hospitalization, through
contact tracing and burial teams. While cases found through
contact tracing may be less biased with regards to severity,
both notification via hotlines or through hospitalization
may be somewhat biased towards more severe cases as
these may be more likely to seek care, while on the other
hand for a disease as severe as Ebola the patients reaching
a TC before dying may be a sample that is skewed towards
survivors. Burial teams would likely primarily identify
cases found post-mortem and therefore this subset is likely
highly biased towards death. Unfortunately, no information
on the mechanisms by which individual cases enter the data-
base was recorded, and it is therefore not possible to assess
the impact this has on CFR estimates. Recording this type
of information would be a valuable addition to data collec-
tion and should be included routinely in any outbreak
investigation. Here, we aimed to reduce the most severe
bias associated with underreporting by excluding cases for
which the clinical outcome was already known on the date
of reporting, as these were dominated by cases found by
burial teams.
Secondly, reporting of the definitive clinical outcome was
incomplete with data missing from nearly half of the cases in
the database. Outcome reporting rates in confirmed cases
were near complete in Guinea, but less than 40% in Sierra
Leone. Clearly, if the probability of the clinical outcome
report differed between survivors and fatalities, the large
amount of missing data could also lead to substantial
biases in CFR estimates. For instance, it is plausible that
deaths may be more likely recorded than survival as the
average delay from onset to death is shorter than from
onset to recovery, therefore loss to follow up may occur
more frequently among survivors than fatalities. Adjusting
for these biases may be possible to some extent and is a
subject of ongoing research. However, it is reassuring that
CFR estimates based on confirmed cases with reported out-
come were fairly consistent between countries, despite the
differences in countries’ reporting practices.
Despite the biases associated with problems in reporting,
we found age to be a clear modifier of survival probability,
with very high values of the CFR in young children (less
than 5 years; figure 2a), decreasing CFR with increasing age
to a minimum at around 15 years, and then increasing with
age to very high values in the elderly. While this effect hasbeen observed in other studies [4,7,10,20,30,31], the large
sample size available here gave a very clear picture of the
age dependence, which we fitted well with a simple two-
parameter model. The fact that despite obvious differences
in reporting practices between countries the age trends are
very similar across all three countries gives confidence that
this is in fact a real biological effect.
We also found differences in CFR between hospitalized
and non-hospitalized cases [11,12], with extremely high
CFRs of around 90% for those not hospitalized or of
unknown hospitalization status, and much lower values in
the range of 40 to 60% for hospitalized cases. Naively, this
could be interpreted as substantial benefit of clinical care.
However, the biases in both case and outcome reporting
are likely to result in lower CFR estimates in hospitalized
than non-hospitalized cases. In particular, follow up and
therefore reporting of the definitive clinical outcome were
likely less complete in the community setting, resulting in
estimates with a stronger bias towards death for those
cases. Furthermore, delays to hospitalization could also
result in a higher CFR in the community setting compared
with hospitalized patients as the most severe cases may die
very quickly, sometimes before they had the opportunity to
reach healthcare facilities due to long distances and limited
transport, skewing the sample of hospitalized cases towards
survivors [32]. While we have found no association between
the delay from symptom onset to hospitalization and clinical
outcome, initial analyses indicate that such effects could
explain the observed difference in CFR between TC and
community settings. While the difference in CFR estimates
between hospitalized and non-hospitalized cases is striking,
caution should be taken when interpreting this result as we
cannot yet quantify the magnitude of the biases of CFR
estimates in the community setting or disentangle the contri-
butions from the different mechanisms that may give rise to
genuine differences in CFR. Further work is needed to
assess the magnitude of the remaining biases.
By contrast, among the more homogeneous population of
hospitalized patients, the observed differences in CFR between
TC types were fairly small and mostly non-significant. While
early hospitalization of cases has been found to be associated
with reduction in transmission intensity [33], the delay from
onset to hospitalization (among hospitalized patients) was
not significantly associated with clinical outcome in this
study. Individual patients’ viral load has been found to be a
strong predictor of survival [7–9]; however, we cannot investi-
gate this finding with the VHF dataset due to data limitations.
The time trends in CFR differed between countries as pre-
viously reported [27], with a decreasing trend found in
Guinea and Liberia, but higher values during the peak than
early or late in the Sierra Leonean epidemic. The decreasing
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CFR values during the peak from August to December
2015 in Sierra Leone could reflect genuinely higher mortality
during this most challenging part of the epidemic. However,
this could equally be caused by preferential reporting of fatal
outcomes, given that outcome reporting rates were lowest
during this period in Sierra Leone. Given the incompleteness
of outcome reporting, any such biases clearly have the poten-
tial to influence the CFR estimates, and further work is
needed to quantitatively assess this effect on CFR estimates.
We examined whether outliers in CFR among districts of
residence or TCs could be identified, recognizing that the
threshold for doing so is higher than for just detecting greater
than expected variation across all districts or TCs. We found
considerable variation in both district- and TC-specific CFRs
over and above what would be expected by chance. For dis-
tricts, we could explain some of this variation by allowing for
case mix in terms of country, age, date of symptom onset
(fitted as a categorical variable) and TC type. Even after the
adjustment, there were a considerable number of districts
with significantly lower or higher CFR than would be
expected for the case mix reported from each district. How-
ever, these were different districts to those that would be
identified based on comparing the individual CFR to the
overall mean, showing the importance of the covariates ident-
ified here.
On the other hand, we were able to explain the majority of
the variation in CFR between TCs by adjusting for covariates
including age, country, date of onset (here fitted as a linear
trend rather than a categorical variable) and TC type, indicat-
ing that standards of clinical care may not have differed
enough between TCs to affect patient outcomes. This could
be either because they were fairly homogeneous between
TCs, or because the levels of clinical care available in the
resource-poor West African setting were simply not sufficient
to make much of a difference. This is also plausible in the
context of little differences between TC types, but would be
in contrast with the experience with cases among western
healthcare workers who were med-evacuated and cared for
in state-of-the-art high dependency units that resulted in
considerably lower mortality [34,35]. However, the few out-
liers identified would be good candidates for further
selective investigation, to identify the characteristics that set
these apart, based on complementary datasets, e.g. from
MSF (Me´dicins Sans Frontie`res). In particular, it could be
extremely informative to compare data on referral routes
into each ETU to explain the remaining variability in CFRbetween ETUs as one might expect that confirmed cases
referred from other healthcare units would have higher survi-
val chances at the point of referral (as they had probably
survived for several days already) than those admitted
early on as suspected cases.
This epidemic was the largest outbreak of EVD in history
by two orders of magnitude, and overwhelmed the fragile
healthcare systems in the affected countries. Local and inter-
national agencies mounted an enormous public health
response in logistically challenging settings. While the focus
during this time clearly was on patient care and the interrup-
tion of transmission, the epidemiological dataset collected
throughout is extremely detailed and rich despite its shortcom-
ings. The biases stemming from the mechanisms of data
collection mean that thoughtful analysis is needed and results
must be interpreted with care. However, the large sample size
and regional scope allowed us to investigate patterns more
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